Previous studies indicated CYFIP2 was downregulated in ccRCC patients due to its DNA methylation, and it was involved in the metabolic reprogramming, the EMT pathway, and immune infiltration processes in ccRCC by its DNA methylation [31]. The gene discussed is CYFIP2; the disease is nonpapillary renal cell carcinoma.